We use cookies to understand how you use our site and to improve your experience.
This includes personalizing content and advertising.
By pressing "Accept All" or closing out of this banner, you consent to the use of all cookies and similar technologies and the sharing of information they collect with third parties.
You can reject marketing cookies by pressing "Deny Optional," but we still use essential, performance, and functional cookies.
In addition, whether you "Accept All," Deny Optional," click the X or otherwise continue to use the site, you accept our Privacy Policy and Terms of Service, revised from time to time.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
Will Revenue Contraction Hinder Corning's (GLW) Q2 Earnings?
Read MoreHide Full Article
Corning Incorporated (GLW - Free Report) is scheduled to report its second-quarter 2023 results on Jul 25, before the opening bell. In the last reported quarter, the communications components provider beat the Zacks Consensus Estimate of 39 cents. Corning delivered a trailing four-quarter earnings surprise of 3.44%, on average.
The company is expected to have registered lower revenues year over year, owing to inflationary pressure, weakness in several end markets and macroeconomic headwinds.
Factors at Play
During the second quarter, Corning signed a joint venture agreement with SGD Pharma to establish a new glass tubing facility in India. The collaboration aims to expand pharmaceutical manufacturing capability in the subcontinent, enabling quicker and more efficient delivery of crucial medications. Leveraging proprietary technology, Corning’s Velocity Vials — borosilicate vials with patented uniform coating — optimize manufacturing efficiency and reduce production costs.
The Velocity Vial technology platform offers easy access to pharma and biotech companies into Corning’s game-changing pharmaceutical packaging technology. It elevates the quality of vials, boosts productivity on filling lines and accelerates the global delivery of injectable medicine.
On the other hand, strategic partnerships with pharma firms enable the company to extend its manufacturing footprint, localize its supply chains and facilitate the sale of Velocity Vials through an extensive network of selling partners. It is likely to have had a positive impact on the second-quarter performance.
In the quarter under review, Corning announced a 20% hike in its display glass substrate prices across all geographic regions. This decision comes in response to the escalation of production costs, as the company revealed that it is forced to pass on the inflated raw material and energy costs to consumers to sustain profitability.
Despite improved market conditions in China and the recovery of panel maker utilization, inflationary pressure remains a major concern in Display Technologies. Demand softness in the smartphone and IT end market, combined with macroeconomic headwinds is straining margins.
Inventory adjustments and lower demand for COVID-related products are affecting net sales in the Life Sciences segment. The display and optical segments account for around 59% of total revenues. This lack of end market diversification makes it vulnerable to economic cycles and augments business risk.
Our estimate for revenues from the Optical Communications vertical is pegged at $1205.6 million. For the Display Technologies segment, our estimate for revenues is pegged at $791.5 million. Our estimate for revenues from the Specialty Materials and Environmental Technologies is pegged at $420 million and $378.7 million, respectively.
For the June quarter, the Zacks Consensus Estimate for revenues is pegged at $3,468 million. The company reported revenues of $3,762 million in the year-ago quarter. The consensus estimate for adjusted earnings per share stands at 45 cents, which suggests a decline from the year-ago tally of 57 cents.
Earnings Whispers
Our proven model does not predict an earnings beat for Corning in the second quarter. The combination of a positive Earnings ESP and a Zacks Rank #1 (Strong Buy), 2 (Buy) or 3 (Hold) increases the chances of an earnings beat. That is not the case here.
Earnings ESP: Earnings ESP, which represents the difference between the Most Accurate Estimate and the Zacks Consensus Estimate, is -1.60%. The Most Accurate Estimate is pegged at 44 cents while the Zacks Consensus Estimate stands at 45 cents. You can uncover the best stocks to buy or sell before they’re reported with our Earnings ESP Filter.
Here are some companies you may want to consider, as our model shows that these have the right combination of elements to post an earnings beat this season:
Meta Platforms (META - Free Report) has an Earnings ESP of +5.83% and carries a Zacks Rank of 2. The company is set to report quarterly numbers on Jul 26.
T-Mobile US, Inc. (TMUS - Free Report) has an Earnings ESP of +3.94% and a Zacks Rank of 2. The company is scheduled to report quarterly numbers on Jul 27.
Image: Bigstock
Will Revenue Contraction Hinder Corning's (GLW) Q2 Earnings?
Corning Incorporated (GLW - Free Report) is scheduled to report its second-quarter 2023 results on Jul 25, before the opening bell. In the last reported quarter, the communications components provider beat the Zacks Consensus Estimate of 39 cents. Corning delivered a trailing four-quarter earnings surprise of 3.44%, on average.
The company is expected to have registered lower revenues year over year, owing to inflationary pressure, weakness in several end markets and macroeconomic headwinds.
Factors at Play
During the second quarter, Corning signed a joint venture agreement with SGD Pharma to establish a new glass tubing facility in India. The collaboration aims to expand pharmaceutical manufacturing capability in the subcontinent, enabling quicker and more efficient delivery of crucial medications. Leveraging proprietary technology, Corning’s Velocity Vials — borosilicate vials with patented uniform coating — optimize manufacturing efficiency and reduce production costs.
The Velocity Vial technology platform offers easy access to pharma and biotech companies into Corning’s game-changing pharmaceutical packaging technology. It elevates the quality of vials, boosts productivity on filling lines and accelerates the global delivery of injectable medicine.
On the other hand, strategic partnerships with pharma firms enable the company to extend its manufacturing footprint, localize its supply chains and facilitate the sale of Velocity Vials through an extensive network of selling partners. It is likely to have had a positive impact on the second-quarter performance.
In the quarter under review, Corning announced a 20% hike in its display glass substrate prices across all geographic regions. This decision comes in response to the escalation of production costs, as the company revealed that it is forced to pass on the inflated raw material and energy costs to consumers to sustain profitability.
Despite improved market conditions in China and the recovery of panel maker utilization, inflationary pressure remains a major concern in Display Technologies. Demand softness in the smartphone and IT end market, combined with macroeconomic headwinds is straining margins.
Inventory adjustments and lower demand for COVID-related products are affecting net sales in the Life Sciences segment. The display and optical segments account for around 59% of total revenues. This lack of end market diversification makes it vulnerable to economic cycles and augments business risk.
Our estimate for revenues from the Optical Communications vertical is pegged at $1205.6 million. For the Display Technologies segment, our estimate for revenues is pegged at $791.5 million. Our estimate for revenues from the Specialty Materials and Environmental Technologies is pegged at $420 million and $378.7 million, respectively.
For the June quarter, the Zacks Consensus Estimate for revenues is pegged at $3,468 million. The company reported revenues of $3,762 million in the year-ago quarter. The consensus estimate for adjusted earnings per share stands at 45 cents, which suggests a decline from the year-ago tally of 57 cents.
Earnings Whispers
Our proven model does not predict an earnings beat for Corning in the second quarter. The combination of a positive Earnings ESP and a Zacks Rank #1 (Strong Buy), 2 (Buy) or 3 (Hold) increases the chances of an earnings beat. That is not the case here.
Earnings ESP: Earnings ESP, which represents the difference between the Most Accurate Estimate and the Zacks Consensus Estimate, is -1.60%. The Most Accurate Estimate is pegged at 44 cents while the Zacks Consensus Estimate stands at 45 cents. You can uncover the best stocks to buy or sell before they’re reported with our Earnings ESP Filter.
Corning Incorporated Price and EPS Surprise
Corning Incorporated price-eps-surprise | Corning Incorporated Quote
Zacks Rank: Corning has a Zacks Rank #3.
Stocks to Consider
Here are some companies you may want to consider, as our model shows that these have the right combination of elements to post an earnings beat this season:
Alphabet Inc. (GOOGL - Free Report) is set to release quarterly numbers on Jul 25. It has an Earnings ESP of +2.49% and carries a Zacks Rank #2. You can see the complete list of today’s Zacks #1 Rank stocks here.
Meta Platforms (META - Free Report) has an Earnings ESP of +5.83% and carries a Zacks Rank of 2. The company is set to report quarterly numbers on Jul 26.
T-Mobile US, Inc. (TMUS - Free Report) has an Earnings ESP of +3.94% and a Zacks Rank of 2. The company is scheduled to report quarterly numbers on Jul 27.
Stay on top of upcoming earnings announcements with the Zacks Earnings Calendar.